Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.185
-0.325 (-12.95%)
Mar 5, 2026, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Zentalis Pharmaceuticals stock have an average target of 6.60, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 202.06% from the current stock price of 2.19.
Analyst Consensus: Buy
* Price targets were last updated on Nov 12, 2025.
Analyst Ratings
The average analyst rating for Zentalis Pharmaceuticals stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $4 | Hold | Maintains | $8 → $4 | +83.07% | Nov 12, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +128.83% | Aug 7, 2025 |
| Wedbush | Wedbush | Hold Reiterates $4 | Hold | Reiterates | $4 | +83.07% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +357.67% | May 15, 2025 |
| Wedbush | Wedbush | Hold Reiterates $4 | Hold | Reiterates | $4 | +83.07% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
n/a
from 67.43M
Revenue Next Year
n/a
EPS This Year
-2.02
from -2.33
EPS Next Year
-1.90
from -2.02
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.73 | -1.37 | ||||
| Avg | -2.02 | -1.90 | ||||
| Low | -3.15 | -3.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.